A semimechanistic and mechanistic population PK–PD model for biomarker response to ibandronate, a new bisphosphonate for the treatment of osteoporosis

समान संसाधन

• Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis
  द्वारा: Bauss, Frieder, और अन्य
  प्रकाशित: (2006)
• Commentary on Dartois et al. – model building in population PK–PD analyses. A 2002–2004 literature survey
  द्वारा: Pillai, Goonaseelan (Colin), और अन्य
  प्रकाशित: (2007)
• The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies –CYP2C9 and warfarin as an example
  द्वारा: Dickinson, Gemma L, और अन्य
  प्रकाशित: (2007)
• Population pharmacokinetics and concentration–effect relationships of capecitabine metabolites in colorectal cancer patients
  द्वारा: Gieschke, Ronald, और अन्य
  प्रकाशित: (2003)
• Overview of model-building strategies in population PK/PD analyses: 2002–2004 literature survey
  द्वारा: Dartois, C, और अन्य
  प्रकाशित: (2007)